다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
ID Biomedical - Common Shares (MM) (IDBE)
ID Biomedical - Common Shares (MM) (IDBE) 뉴스

IDBE

ID Biomedical (IDBE)

ID Biomedical - Common Shares (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IDBE

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2005/12/09	00:00	PR Newswire (US)	ID Biomedical announces closing of acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/12/07	10:40	PR Newswire (US)	ID Biomedical announces receipt of court approval for acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/12/05	23:15	PR Newswire (US)	ID Biomedical provides update on application for court approval of acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/11/19	07:06	PR Newswire (US)	ID Biomedical announces rescheduling of court hearing to approve acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/11/17	07:28	PR Newswire (US)	ID Biomedical announces results of securityholders' votes relating to acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/11/11	00:28	PR Newswire (US)	ID Biomedical reports 2005 third quarter results	NASDAQ:IDBE
2005/10/24	23:40	PR Newswire (US)	ID Biomedical Provides Update on Vaccine Development Programs	NASDAQ:IDBE
2005/10/21	08:54	PR Newswire (US)	ID Biomedical announces mailing of meeting materials	NASDAQ:IDBE
2005/09/08	01:06	PR Newswire (US)	GlaxoSmithKline To Acquire ID Biomedical Corporation	NASDAQ:IDBE
2005/09/08	00:31	PR Newswire (US)	GlaxoSmithKline To Acquire ID Biomedical Corporation	NASDAQ:IDBE	ID Biomedical - Common Shares (MM)
2005/08/16	06:00	PR Newswire (US)	ID Biomedical reports 2005 second quarter results	NASDAQ:IDBE
2005/08/11	04:10	PR Newswire (US)	ID Biomedical announces 2005 second quarter release date and conference call	NASDAQ:IDBE
2005/07/12	23:00	PR Newswire (US)	ID Biomedical's flu vaccine granted Fast Track status by FDA	NASDAQ:IDBE
2005/05/26	23:30	PR Newswire (US)	ID Biomedical announces webcast of 2005 Annual General Meeting of Shareholders	NASDAQ:IDBE
2005/05/21	00:57	PR Newswire (US)	ID Biomedical announces webcast of 2005 Annual General Meeting of Shareholders	NASDAQ:IDBE
2005/05/17	06:00	PR Newswire (US)	ID Biomedical reports 2005 first quarter results	NASDAQ:IDBE
2005/05/11	23:30	PR Newswire (US)	ID Biomedical announces 2005 first quarter release date and conference call	NASDAQ:IDBE
2005/03/31	00:42	PR Newswire (US)	ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral Clinical Trial in the U.S.	NASDAQ:IDBE
2005/03/23	00:04	PR Newswire (US)	ID Biomedical receives positive data from clinical testing of its Group-Common Pneumococcal Vaccine	NASDAQ:IDBE
2005/03/17	06:01	PR Newswire (US)	ID Biomedical reports fiscal 2004 year end results	NASDAQ:IDBE
2005/03/15	23:30	PR Newswire (US)	ID Biomedical to pursue U.S. accelerated approval process for its influenza vaccine	NASDAQ:IDBE
2005/03/15	00:40	PR Newswire (US)	ID Biomedical announces 2004 year end earnings release date and conference call	NASDAQ:IDBE
2005/03/04	23:30	PR Newswire (US)	ID Biomedical closes sale and leaseback transactions	NASDAQ:IDBE
2005/01/26	23:15	PR Newswire (US)	ID Biomedical Announces Immunogenicity Results from Phase II Trial of Streptavax	NASDAQ:IDBE
2005/01/19	23:15	PR Newswire (US)	ID Biomedical begins development of pandemic influenza vaccine	NASDAQ:IDBE
2005/01/14	01:34	PR Newswire (US)	ID Biomedical announces final results from field efficacy trial of its intranasal flu vaccine	NASDAQ:IDBE
2005/01/11	01:16	PR Newswire (US)	ID Biomedical announces the beginning of a U.S. phase I clinical trial for plague vaccine candidate	NASDAQ:IDBE
2005/01/10	23:15	PR Newswire (US)	ID Biomedical Closes Financing Transaction	NASDAQ:IDBE
2005/01/10	23:01	PR Newswire (US)	CSC's DVC Enters Clinical Trial for Plague Vaccine Candidate	NASDAQ:IDBE	ID Biomedical - Common Shares (MM)
2005/01/07	23:15	PR Newswire (US)	ID Biomedical receives clearance for Fluviral clinical testing in the U.S.	NASDAQ:IDBE

검색 관련기사 보기:NASDAQ:IDBE

1 2 3 다음 >>

Waterstone Financial

TKK Symphony Acquisition

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관